Wire Stories
-
369Shipments of AI Servers Will Climb at CAGR of 10.8% from 2022 to 2026, Says TrendForce
TAIPEI, Taiwan–(BUSINESS WIRE)–#AI–According to TrendForce�s latest survey of the server market, many cloud service providers (CSPs) have begun large-scale investments in the...
-
430Shipments of AI Servers Will Climb at CAGR of 10.8% from 2022 to 2026, Says TrendForce
TAIPEI, Taiwan–(BUSINESS WIRE)–#AI–According to TrendForce�s latest survey of the server market, many cloud service providers (CSPs) have begun large-scale investments in the...
-
375Asia Pacific Spintronics Market Report to 2031: Players Include Avalanche Technology, Crocus Technology, Everspin Technologies, IBM and Intel – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Spintronics Market 2021-2031 by Device Type, Application, Industry Vertical, and Country: Trend Forecast and Growth Opportunity” report has...
-
339
Asia Pacific Spintronics Market Report to 2031: Players Include Avalanche Technology, Crocus Technology, Everspin Technologies, IBM and Intel – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Spintronics Market 2021-2031 by Device Type, Application, Industry Vertical, and Country: Trend Forecast and Growth Opportunity” report has...
-
416
Asia Pacific Spintronics Market Report to 2031: Players Include Avalanche Technology, Crocus Technology, Everspin Technologies, IBM and Intel – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Spintronics Market 2021-2031 by Device Type, Application, Industry Vertical, and Country: Trend Forecast and Growth Opportunity” report has...
-
369Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
TOKYO–(BUSINESS WIRE)–Sumitomo Heavy Industries, Ltd. (�SHI�) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in...
-
405Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
TOKYO–(BUSINESS WIRE)–Sumitomo Heavy Industries, Ltd. (�SHI�) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in...
-
387Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
TOKYO–(BUSINESS WIRE)–Sumitomo Heavy Industries, Ltd. (�SHI�) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in...
-
393Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8008, an Antibody-Drug Conjugate Targeting Trop2 for the Treatment of Advanced Solid Tumors
GUANGZHOU, China–(BUSINESS WIRE)–#ADC–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical...
-
360Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8008, an Antibody-Drug Conjugate Targeting Trop2 for the Treatment of Advanced Solid Tumors
GUANGZHOU, China–(BUSINESS WIRE)–#ADC–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical...
